Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) is a neurodegenerative disorder that primarily affects male carriers of the FMR1 gene premutation, characterized by an expansion of CGG ...
Truist has initiated coverage of Larimar Therapeutics (NASDAQ:LRMR) with a buy rating, citing an "asymmetric" risk/reward ahead of regulatory updates for its drug candidate nomla for Friedreich’s ...
Leerink Partners analyst Joseph Schwartz has reiterated their bullish stance on LRMR stock, giving a Buy rating on January 24.Invest with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback